Correlation between lower c-mpl protein expression and favorable cytogenetic groups in acute myeloid leukemia

Leukemia Research

Volumn 23, Issue 1, 1999, Pages 63-69

  Albitar, Maher ^a   Manshouri, Taghi ^a   Kantarjian, Hagop ^a   Keating, Michael ^a   Estrov, Zeev ^a   Faber, Joana ^a   Freireich, Emil J ^a   Pierce, Sherry ^a   Estey, Elihu ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Acute myeloid leukemia; c mpl; Cytogenetic group; Survival; Thrombopoietin (TPO)

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CONTROLLED STUDY; CYTOGENETICS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY;

BLOTTING, WESTERN; BONE MARROW; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; MIDDLE AGED; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; RADIOIMMUNOASSAY; RECEPTORS, CYTOKINE; RECEPTORS, THROMBOPOIETIN; RNA, MESSENGER; SURVIVAL ANALYSIS;

EID: 0032889702     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00132-5     Document Type: Article

References (21)

1. Vigon I, Mormon JP, Cocault L, Mitjavila MT, Tambourin P, Gisselbrecht S, Souyri M. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: Identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 1992;89:5640.
2. Hartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samal B, Nichol JL. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994;77:1117.
3. de Sauvage FJ, Hass PE, Spencer SD. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369:533.
4. Lok SL, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Heipel MD, Burkhead SK, Kramer JM. Cloning and expression of murin thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994;369:565.
5. Kaushansky K, Lok SL, Holly RD, Broudy VC, Lin N, Bailey MC, Forstrom JW, Buddle MM, Oort PJ, Hagen FS. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994;369:568.
6. Wendling F, Maraskovsky E, Debili N, Florindo C, Teepe M, Titeux M, Methia N, Breton-Gorius J, Cosman D, Vainchenker W. c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 1994;369:571.
7. Mignotte V, Vigon I, de Crevecoeur EB, Romeo P-H, Lemarchandel V, Chretien S. Structure and transcription of the human c-mpl gene (MPL). Genomics 1994;20:5.
8. Debili N, Wendling F, Cosman D, Titeux M, Florindo C, Dusanter-Fourt I, Schooley K, Methia N, Charon M, Nador R, Bettaieb A, Vainchenker W. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 1995;85:391.
9. Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW. Thrombocytopenia in c-mpl-deficient mice. Science 1994;265: 1445.
10. Alexander WS, Roberts AW, Nicola NA, Li R, Metcalf D. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-mpl. Blood 1996;87:2162.
11. Cosman D, Lyman SD, Idzerda RL, Beckman MP, Park LS, Goodwin RG, March CJ. A new cytokine receptor superfamily. Trends Biochem Sci 1990;15:265.
12. Bouscary D, Preudhomme C, Ribrag V, Melle J, Viguie F, Picard F, Guesnu M, Fenaux P, Gisselbrecht S, Dreyfus F. Prognostic value of c-mpl expression in myelodysplastic syndromes. Leukemia 1995;9:783.
13. Wetzler M, Baer MR, Bernstein SH, Blumenson L, Stewart C, Barcos M, Mrozek K, Block AMW, Herzig GP, Bloomfield CD. Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy. J Clin Oncol 1997;15:2262.
14. Quentmeier H, Zaborski M, Graf G, Ludwig WD, Drexler HG. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells. Leukemia 1996;10:297.
15. Atassi MZ, Dolimbek BZ, Manshouri T. Antibody and T-cell recognition of α-bungarotoxin and its synthetic loop-peptides. Mol Immunol 1995;32:919.
16. Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M. Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy. Blood 1997;90:2969.
17. Keating MJ, Smith TL, Kantarjian H, Cork A, Walters R, Trujillo JM, McCredie KB, Gehan EA, Freireich EJ. Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome. Leukemia 1988;2:403.
18. Matsumara I, Kanakura Y, Ikeda H, Ishikawa J, Yoshida H, Horikawa Y, Nishiura T, Tahara T, Kato T, Miyazaki H, Matsuzawa Y. Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells. Leukemia 1996;10:91.
19. Bouscary D, Prudhomme C, Quesnel B, Melle J, Picard F, Dreyfus F. c-mpl expression in hematologic disorders. Leuk Lymphoma 1995;17:19.
20. Le Conniat M, Souyri M, Vigon I, Wendling F, Tambourin P, Berger R. The human homolog of the myeloproliferative virus maps to chromosome band 1p34. Hum Genet 1989;83:194.
21. Methia N, Louache F, Vainchenker W, Wendling F. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 1993;82:1395.